Found 32 matching trials
A Study of Oral Valcyte (Valganciclovir) in Pediatric Kidney Transplant Recipients
PHASE4This open-label, single arm study will evaluate the tolerability and effica...
Location
University of Florida Pediatric Nephrology
Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults
PHASE1Transplant rejection occurs when a patient's body does not recognize the ne...
Location
University of Wisconsin - Department of Medicine
Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II
PHASE2The goal of this clinical trial is to compare antiviral treatment strategie...
Location
Stein Eye Institute, University of California Los Angeles
Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease
PHASE4The purpose of the study is to learn whether people who are experiencing an...
Location
Multiple Locations
Pharmacokinetic Parameters of Innovative Valganciclovir Versus Generic Valganciclovir
NACytomegalovirus (CMV) is the most common opportunistic viral pathogen in so...
Location
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
The Strategy in the Prevention of Renal Post-transplant Cytomegalovirus Infection Among Chinese Population
N/AThis study evaluates the safety and availability of oral valganciclovir(VGC...
Location
the First Affiliated Hospital of Xi'an Jiaotong University
Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fasting Condition
PHASE1This study is to assess the Valganciclovir Hydrochloride Tablets 450 mg of ...
Location
Lambda Therapeutic Research Ltd
Letermovir Versus Valganciclovir to Prevent Human Cytomegalovirus Disease in Kidney Transplant Recipients (MK-8228-002)
PHASE3The primary objective of this study is to evaluate the efficacy of letermov...
Efficacy of Letermovir in Preventing Cytomegalovirus (CMV) Infection in Lung Transplant Recipients vs. Valganciclovir.
PHASE2The goal of this quasi-experimental multicenter before-after cohort study, ...
Location
Hospital Universitario Reina Sofia
Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV+ Lymphoid Malignancies
PHASE1A two part, Phase 1b/2 study to define a recommended Phase 2 dose of VRx-39...
Location
USC Norris Comprehensive Cancer Center